Chester County News and Community Website
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS this week announced a delay in the release of Phase III study data for its promising Parkinson’s Disease drug, buntanetap. The postponement …
Annovis Bio Postpones Release of Phase III Data for Parkinson’s Disease Drug, Buntanetap Read More
MALVERN, PA — In a bid to bolster psychopharmacology education, HMP Global’s Psych Congress NP Institute has launched its new Online Learning Hub. This move marks a significant stride in …
HMP Global Launches Online Learning Hub for Psychiatric Nurse Practitioners Read More
WAYNE, PA — Neuraptive Therapeutics Inc. recently announced that its novel treatment for peripheral nerve injury, NTX-001, has received Orphan Drug Designation from the United States Food and Drug Administration …
Neuraptive Therapeutics Earns FDA Orphan Drug Designation for Novel Peripheral Nerve Injury Treatment Read More
EXTON, PA — AmerCareRoyal (“ACR”), a leader in the sustainable packaging industry, has announced its latest innovation, the PrimeWare compostable straw. This product marries the durability of a plastic straw …
AmerCareRoyal Unveils PrimeWare Compostable Straw, Combining Sustainability with Performance Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH), a global manufacturer of discrete semiconductors and passive electronic components, announced that it has upgraded its TSOP18xx, TSOP58xx, and TSSP5xx series of …
Vishay Intertechnology Upgrades Infrared Receiver Modules: A Leap Forward for Remote Control and Proximity Sensing Applications Read More
KENNETT SQUARE, PA — Good Gaming, Inc. (OTCQB: GMER) has announced the release date of its first mobile game, Galactic Acres™. This game is the first in a series of …
Good Gaming’s Galactic Acre: A Web3 Game-Changer Set to Redefine the Mobile Gaming Landscape Read More WAYNE, PA — Neuraptive Therapeutics, Inc., a Pennsylvania-based biotech company, recently announced a major breakthrough in the treatment of peripheral nerve injuries. The firm’s successful demonstration of proof-of-concept in the …
Neuraptive Therapeutics’ Groundbreaking Study Paves Way for Improved Peripheral Nerve Injury Treatment Read More
MALVERN, PA — Venatorx Pharmaceuticals recently granted exclusive commercial rights to Italy’s Menarini Group for its novel antibiotic, cefepime-taniborbactam. The agreement extends to 96 countries in Europe, Latin America, Middle …
Venatorx Pharmaceuticals Strikes Deal with Menarini Group for Global Rights to Cefepime-Taniborbactam Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has released promising top-line results from its Phase 2b study of ATI-1777, a topical “soft” JAK 1/3 inhibitor developed for treating mild …
Aclaris Therapeutics Announces Promising Phase 2b Results for ATI-1777, Boosting Investor Confidence Read More
EXTON, PA — In a strategic bid to modernize and simplify the hiring process in K12 education, Red Rover has announced the launch of Red Rover Hiring, a software solution …
Red Rover Unveils Innovative Hiring Software to Streamline K12 Recruitment Read More